Healthify is banking on the rise of GLP-1 weight-loss drugs in India, integrating them with lifestyle coaching. The firm ...

There are currently no drugs approved in the European Union to treat the liver condition known as MASH, but a new trial of ...

There are several decision tools to help doctors and patients evaluate the potential benefits of cholesterol medication, and ...

Turmeric and its main antioxidant, curcumin, have antioxidant and anti-inflammatory effects. They may reduce pain, boost ...

Todd Engels, 62, from Maryland, started taking Ozempic after he saw glowing headlines and slick ads praising it as a 'miracle ...

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic dysfunction-associated steatohepatitis (MASH) ...

Sodium-glucose cotransporter-2 inhibitors (SGLT2i), or gliflozins, are medications used in the treatment of type 2 diabetes ...

There was a marked increased in the detection of illegal weight loss type medicines, as more than a million units of illegal ...

However, some issues and considerations are specific to those who are older, such as mobility difficulties, differing ...

Diabetes insipidus affects the kidneys but does not concern blood sugar control like diabetes mellitus. Learn about the ...

As broader approval for GLP-1 weight loss drugs spurs higher demand, it’s also causing employer drug spending to spike.

Mukhopadhyay took Mounjaro, an antidiabetic medication also used for weight loss, and saw dramatic results—losing 15 percent of her body weight over 18 months. She was feeling physically better, ...